4.86

0.41% 0.04

Maravai Lifesciences Holdings Inc (MRVI)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt MRVI? Forum Prognose

Schlusskurs vom Vortag:

$4.82

Offen:

$4.85

24-Stunden-Volumen:

272.24K

Relative Volume:

0.16

Marktkapitalisierung:

$656.74M

Einnahmen:

$288.95M

Nettoeinkommen (Verlust:

$-119.03M

KGV:

8.5338

EPS:

0.5695

Netto-Cashflow:

$60.67M

1W Leistung:

-6.92%

1M Leistung:

-43.06%

6M Leistung:

-55.80%

1J Leistung:

-1.83%

1-Tages-Spanne:

$4.745

$4.90

1-Wochen-Bereich:

$4.275

$5.365

52-Wochen-Spanne:

$4.275

$11.55

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Firmenname

Maravai Lifesciences Holdings Inc

Sektor

Healthcare (1195)

Branche

Biotechnology (683)

Telefon

(858) 546-0004

Adresse

10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO

Mitarbeiter

580

Twitter

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

MRVI's Discussions on Twitter

Vergleichen Sie MRVI mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MRVI	4.86	656.74M	288.95M	-119.03M	60.67M	0.5695
VRTX	447.58	115.74B	10.63B	-479.80M	-1.35B	13.33
REGN	741.92	81.65B	13.85B	4.65B	3.32B	35.06
ARGX	589.39	34.86B	1.86B	-40.29M	-1.28B	-4.16
ALNY	248.84	32.09B	2.09B	-332.26M	16.06M	-4.14
BNTX	103.41	24.49B	3.30B	-501.07M	1.03B	11.54

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-08-08	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2023-05-23	Herabstufung	Credit Suisse	Outperform → Neutral
2023-05-09	Herabstufung	Goldman	Buy → Neutral
2023-01-05	Herabstufung	UBS	Buy → Neutral
2022-12-14	Eingeleitet	Deutsche Bank	Buy
2022-12-07	Eingeleitet	RBC Capital Mkts	Outperform
2022-11-03	Herabstufung	BofA Securities	Buy → Neutral
2022-08-25	Eingeleitet	Credit Suisse	Outperform
2021-08-05	Fortgesetzt	Credit Suisse	Outperform
2020-12-16	Eingeleitet	KeyBanc Capital Markets	Overweight
2020-12-15	Eingeleitet	BofA Securities	Buy
2020-12-15	Eingeleitet	Credit Suisse	Outperform
2020-12-15	Eingeleitet	Goldman	Buy
2020-12-15	Eingeleitet	Jefferies	Buy
2020-12-15	Eingeleitet	Robert W. Baird	Outperform
2020-12-15	Eingeleitet	Stifel	Buy
2020-12-15	Eingeleitet	William Blair	Outperform
2020-12-14	Eingeleitet	UBS	Buy

Alle ansehen

Maravai Lifesciences Holdings Inc Aktie (MRVI) Neueste Nachrichten

Nov 20, 2024

Wolfe Research Initiates Coverage of Maravai LifeSciences Holdings (MRVI) with Peer Perform Recommendation - MSN

Nov 20, 2024

Nov 18, 2024

What Do Analysts Think About Maravai LifeSciences Holdings Inc’s (NASDAQ:MRVI) Future? - Stocks Register

Nov 18, 2024

Royce & Associates LP Increases Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat

Nov 18, 2024

Nov 16, 2024

Maravai LifeSciences (NASDAQ:MRVI) Trading Down 7.5%Here's What Happened - MarketBeat

Nov 16, 2024

Maravai LifeSciences shares initiated with Peerperform on positive aspects - Investing.com India

Nov 15, 2024

Maravai lifesci director John DeFord acquires $100,625 in stock - Investing.com

Nov 15, 2024

Nov 14, 2024

Insider Buying: Director John Deford Acquires Shares of Maravai LifeSciences Holdings Inc (MRVI) - GuruFocus.com

Nov 14, 2024

Maravai LifeSciences shares initiated with Peerperform on positive aspects By Investing.com - Investing.com Canada

Nov 14, 2024

Maravai LifeSciences (NASDAQ:MRVI) Now Covered by Wolfe Research - MarketBeat

Nov 14, 2024

Maravai LifeSciences Target of Unusually Large Options Trading (NASDAQ:MRVI) - MarketBeat

Nov 14, 2024

Nov 13, 2024

12 West Capital Management LP's Strategic Acquisition in Maravai LifeSciences Holdings Inc - GuruFocus.com

Nov 13, 2024

Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Up Following Insider Buying Activity - MarketBeat

Nov 13, 2024

Nov 12, 2024

Maravai LifeSciences Announces November 2024 Investor Conference Schedule - GlobeNewswire

Nov 12, 2024

Earnings call: Maravai LifeSciences reports mixed Q3 results, eyes growth - Investing.com India

Nov 12, 2024

Maravai LifeSciences (NASDAQ:MRVI) Price Target Cut to $13.00 by Analysts at Royal Bank of Canada - Defense World

Nov 12, 2024

Nov 11, 2024

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 11, 2024

Slammed 37% Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Screens Well Here But There Might Be A Catch - Simply Wall St

Nov 11, 2024

Nov 10, 2024

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance

Nov 10, 2024

Nov 09, 2024

Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Down on Analyst Downgrade - Defense World

Nov 09, 2024

Maravai Lifesciences price target lowered to $9 from $10 at Baird - Yahoo Finance

Nov 09, 2024

Nov 08, 2024

Health Care Up on Another Round of Mixed Earnings -- Health Care Roundup - Marketscreener.com

Nov 08, 2024

Royal Bank of Canada Has Lowered Expectations for Maravai LifeSciences (NASDAQ:MRVI) Stock Price - MarketBeat

Nov 08, 2024

Maravai LifeSciences stock plunges 39% amid lowered revenue forecast - MSN

Nov 08, 2024

Maravai LifeSciences stock plunges 39% amid lowered revenue forecast (NASDAQ:MRVI) - Seeking Alpha

Nov 08, 2024

U.S. Stock market: Evolent Health(-43.35%), Maravai LifeSciences(-38.65%), and Chanson International(-38.04%) in midday trading - Business Upturn

Nov 08, 2024

Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Down Following Analyst Downgrade - MarketBeat

Nov 08, 2024

U.S. Stock market: Evolent Health (-41.07%), Maravai LifeSciences(-34.44%), Revance Therapeutics(-32.01%) as top losers during early trading - Business Upturn

Nov 08, 2024

Maravai LifeSciences (NASDAQ:MRVI) Given New $9.00 Price Target at Robert W. Baird - MarketBeat

Nov 08, 2024

Maravai LifeSciences' (MRVI) Market Perform Rating Reaffirmed at William Blair - MarketBeat

Nov 08, 2024

Decoding 5 Analyst Evaluations For Maravai LifeSciences - Benzinga

Nov 08, 2024

Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript - AOL

Nov 08, 2024